The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Concentration information loading...
Preparation and Storage
Stability and Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Reconstitute with 50 µl sterile deionized water. For long term storage or for preparation of more diluted working stock solution, a carrier protein (e.g. 1% serum albumin) should be added to the vial.
Death receptor 6
TNFR related death receptor 6
Tumor necrosis factor receptor superfamily member 21
Tumor necrosis factor receptor superfamily member 21 precursor
May activate NF-kappa-B and promote apoptosis. May activate JNK and be involved in T-cell differentiation. Required for both normal cell body death and axonal pruning. Trophic-factor deprivation triggers the cleavage of surface APP by beta-secretase to release sAPP-beta which is further cleaved to release an N-terminal fragment of APP (N-APP). N-APP binds TNFRSF21 triggering caspase activation and degeneration of both neuronal cell bodies (via caspase-3) and axons (via caspase-6).
Highly expressed in heart, brain, placenta, pancreas, lymph node, thymus and prostate. Detected at lower levels in lung, skeletal muscle, kidney, testis, uterus, small intestine, colon, spleen, bone marrow and fetal liver. Very low levels were found in adult liver and peripheral blood leukocytes.
Contains 1 death domain. Contains 4 TNFR-Cys repeats.
SDS-PAGE - Recombinant Human DR6 protein (ab56520)
SDS Page analysis of ab56520: 12% separating gel, 6% stacking gel; reducing conditions, staining with Coomasie Blue.
Lane 1: 2 µg,
Lane 2: 1 µg,
Lane 3: 0.5 µg,
Lane 4: 0.2 µg,
Lane 5: 0.1 µg.
Western blot - Recombinant Human DR6 protein (ab56520)
Western blot analysis of ab56520: 12% separating gel; reducing conditions, immunostaining with rabbit polyclonal antibody specific to DR6. Detection with Goat anti-rabbit / HRP secondary antibody. Amount of ab56520 loaded on each lane: (1) 0.15 µg, (2) 0.075 µg, (3) 0.03 µg, (4) 0.015 µg per lane.
has not yet been referenced specifically in any publications.
Publishing research using ab56520? Please let us know so that we can cite the reference in this datasheet.
Customer reviews and Q&As
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Get resources and offers direct to your inboxSign up